Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Iterum Therapeutics plc (ITRM)

3.98   0.1 (2.58%) 10-15 09:34
Open: 4.08 Pre. Close: 3.88
High: 4.08 Low: 3.9
Volume: 4,901 Market Cap: 51M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 4.499 - 4.524 4.524 - 4.552
Low: 3.738 - 3.762 3.762 - 3.789
Close: 3.833 - 3.876 3.876 - 3.923

Technical analysis

as of: 2019-10-14 4:47:17 PM
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 6.63     One year: 7.98
Support: Support1: 3.80    Support2: 3.16
Resistance: Resistance1: 5.67    Resistance2: 6.83
Pivot: 5.29
Moving Average: MA(5): 4.32     MA(20): 5.56
MA(100): 6.38     MA(250): 6.52
MACD: MACD(12,26): -0.57     Signal(9): -0.39
Stochastic oscillator: %K(14,3): 10.16     %D(3): 10.57
RSI: RSI(14): 21.47
52-week: High: 9.30  Low: 3.80  Change(%): -36.8
Average Vol(K): 3-Month: 1246  10-Days: 2771

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
ITRM has closed above bottom band by 5.6%. Bollinger Bands are 191.6% wider than normal. The large width of the bands suggest high volatility as compared to ITRM's normal range. The bands have been in this wide range for 5 bars. This is a sign that the current trend might continue.

Headline News

Iterum Therapeutics PLC (ITRM) Reports Q2 Loss, Misses Revenue Estimates
Iterum Therapeutics PLC (ITRM) delivered earnings and revenue surprises of -17.68% and -100.00%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Iterum Therapeutics PLC (ITRM) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
Iterum Therapeutics PLC (ITRM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 14.42
Shares Float (M) 4.54
% Held by Insiders 8.97
% Held by Institutions 75.71
Shares Short (K) 86
Shares Short P. Month (K)

Stock Financials

EPS -7.047
Book Value (p.s.) 1.710
PEG Ratio
Profit Margin
Operating Margin -18259.24
Return on Assets (ttm) -55.8
Return on Equity (ttm) -136.1
Qtrly Rev. Growth
Gross Profit (p.s.) 0.060
Sales Per Share
EBITDA (p.s.) -6.701
Qtrly Earnings Growth
Operating Cash Flow (M) -84.78
Levered Free Cash Flow (M) -49.15

Stock Valuations

P/E -0.55
P/E Growth Ratio -0.10
P/BV 2.27
P/S 1398740096.00
P/CF -0.66

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.